RIPK1-IN-19

RIPK1-IN-19 (compound 10b), a selective RIPK1 inhibitor (IC50 = 15 nM), demonstrates significant protective activity in TNFα-induced systemic inflammatory response syndrome (SIRS) and Imiquimod (IMQ)-induced psoriasis models. This compound is suitable for research on inflammation and immune system diseases [1].